320 results on '"de Vos-Geelen, Judith"'
Search Results
2. Longitudinal associations of diurnal rest-activity rhythms with fatigue, insomnia, and health-related quality of life in survivors of colorectal cancer up to 5 years post-treatment
3. Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer
4. Tackling challenges in rare diseases: The ISGACA approach on non-pancreatic cancers in the periampullary region
5. Validation of an automated segmentation method for body composition analysis in colorectal cancer patients using diagnostic abdominal computed tomography images
6. Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysis
7. Altered whole blood thrombin generation and hyperresponsive platelets in patients with pancreatic cancer
8. Cannabinoid consumption among cancer patients receiving systemic anti-cancer treatment in the Netherlands
9. Nationwide evaluation of pancreatic cancer networks ten years after the centralization of pancreatic surgery
10. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
11. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer
12. Practice variation in venous resection during pancreatoduodenectomy for pancreatic cancer: A nationwide cohort study
13. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database
14. Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon
15. The fear of cancer recurrence and progression in patients with pancreatic cancer
16. Impact of multicentre diagnostic workup in patients with pancreatic cancer on repeated diagnostic investigations, time-to-diagnosis and time-to-treatment: A nationwide analysis
17. Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study
18. Perioperative and long-term outcome of en-bloc arterial resection in pancreatic surgery
19. Chyle Leak After Pancreatoduodenectomy: Clinical Impact and Risk Factors in a Nationwide Analysis
20. Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)
21. The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine
22. Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
23. Diagnostic accuracy of cross-sectional and endoscopic imaging in ampullary tumours: systematic review
24. A population-based study on incidence, treatment, and survival in ampullary cancer in the Netherlands
25. Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort
26. Surgical management and pathological assessment of pancreatoduodenectomy with venous resection: an international survey among surgeons and pathologists
27. Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up
28. Nerve fibers in the tumor microenvironment in neurotropic cancer—pancreatic cancer and cholangiocarcinoma
29. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer.
30. Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial)
31. Impact of nationwide implementation of best practices in pancreatic cancer care (PACAP-1): a stepped-wedge cluster randomised controlled trial
32. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
33. Influence of Contrast Material Temperature on Patient Comfort and Image Quality in Computed Tomography of the Abdomen: A Randomized Controlled Trial
34. Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study
35. Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial
36. Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancer
37. Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review
38. Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial
39. Physical Fitness and Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: An Observational Study
40. Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial)
41. Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial)
42. Study design of prebiotic intervention in metastatic colorectal cancer patients treated with 5-FU based chemotherapy: a clinical intervention study.
43. Influence of surgery and perioperative antibiotic use on the intestinal microbiota of breast cancer patients
44. Outcomes, treatment and risk factors of portomesenteric venous thrombosis following venous resection during pancreatoduodenectomy for pancreatic cancer: A multicenter retrospective analysis
45. Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival
46. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer
47. Functional status decline in older patients with breast and colorectal cancer after cancer treatment: A prospective cohort study
48. Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial.
49. Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer
50. Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.